Low SARS-CoV-2 Antibodies in Blood Donors After the First 6 Months of COVID-19 Epidemic in the Tobruk Region, Eastern Libya.
作者信息
Ismail Faisal, Farag Atiya, Haq Soghra, Kamal Mohammad Amjad
机构信息
Clinical Laboratory Department, Faculty of Medical Technology, University of Tobruk, Tobruk, Libya.
National Centre for Disease Control, Tobruk, Libya.
出版信息
Disaster Med Public Health Prep. 2022 Jul 27:1-2. doi: 10.1017/dmp.2022.180.
Abstract
摘要
相似文献
1
Low SARS-CoV-2 Antibodies in Blood Donors After the First 6 Months of COVID-19 Epidemic in the Tobruk Region, Eastern Libya.利比亚东部托布鲁克地区新冠疫情爆发头6个月后献血者体内的新冠病毒抗体水平较低。
Disaster Med Public Health Prep. 2022 Jul 27:1-2. doi: 10.1017/dmp.2022.180.
2
Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses.无症状 SARS-CoV-2 感染病例的血清学调查显示，抗体反应较弱且逐渐减弱。
Emerg Microbes Infect. 2021 Dec;10(1):905-912. doi: 10.1080/22221751.2021.1919032.
3
SARS COV-2- IgG antibodies in blood donors in pandemic - A game changer for policy makers.血源中 SARS-CoV-2 IgG 抗体——政策制定者的游戏规则改变者。
Transfus Clin Biol. 2022 Feb;29(1):11-15. doi: 10.1016/j.tracli.2021.10.004. Epub 2021 Oct 13.
4
COVID-19 epidemic in Libya.利比亚的 COVID-19 疫情。
Libyan J Med. 2021 Dec;16(1):1871798. doi: 10.1080/19932820.2021.1871798.
5
The rate of SARS-CoV-2 among asymptomatic non-immunised low-risk parturient women between the two waves.两波疫情期间无症状未免疫低危产妇人群中的 SARS-CoV-2 流行率。
J Obstet Gynaecol. 2022 Aug;42(6):1868-1873. doi: 10.1080/01443615.2022.2049720. Epub 2022 Apr 29.
6
Characteristics of US Blood Donors Testing Reactive for Antibodies to SARS-CoV-2 Prior to the Availability of Authorized Vaccines.在授权疫苗可用之前，美国新冠病毒抗体检测呈反应性的献血者特征。
Transfus Med Rev. 2021 Jul;35(3):1-7. doi: 10.1016/j.tmrv.2021.07.001. Epub 2021 Jul 30.
7
Cancer incidence in the Tobruk area, eastern Libya: first results from Tobruk Medical Centre.利比亚东部托布鲁克地区的癌症发病率：来自托布鲁克医疗中心的初步结果。
Epidemiol Health. 2021;43:e2021050. doi: 10.4178/epih.e2021050. Epub 2021 Aug 3.
8
Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening".使用多种 SARS-CoV-2 血清学检测方法对纽约市地铁献血者队列中抗 SARS-CoV-2 抗体的血清流行率进行检测：对控制疫情和“重新开放”的影响。
PLoS One. 2021 Apr 28;16(4):e0250319. doi: 10.1371/journal.pone.0250319. eCollection 2021.
9
Risk factors and predictors that influence SARS-Cov-2 IgG positivity: A cross-sectional study of blood donors in Riyadh, Saudi Arabia.影响 SARS-CoV-2 IgG 阳性的风险因素和预测因素：沙特阿拉伯利雅得献血者的横断面研究。
Saudi Med J. 2021 Aug;42(8):853-861. doi: 10.15537/smj.2021.42.8.20210238.
10
SARS-CoV-2 neutralizing capacity among blood donors without prior COVID-19 symptomatic history vs. blood donors with prior COVID-19 symptomatic history: A comparative study.无既往 COVID-19 症状史与有既往 COVID-19 症状史的献血者中 SARS-CoV-2 中和能力的比较研究。
Transfus Clin Biol. 2022 May;29(2):107-111. doi: 10.1016/j.tracli.2022.02.004. Epub 2022 Feb 12.
本文引用的文献
1
Exploiting epidemiological data to understand the epidemiology and factors that influence COVID-19 pandemic in Libya.利用流行病学数据了解利比亚新冠肺炎疫情的流行病学特征及影响因素。
World J Virol. 2021 Jul 25;10(4):156-167. doi: 10.5501/wjv.v10.i4.156.
2
Clinical Characteristics of the First 100 Patients of COVID-19 in Tobruk, Libya: A Brief Report From Low-Resource Settings.利比亚托布鲁克首批100例新冠肺炎患者的临床特征：来自资源匮乏地区的简要报告
Disaster Med Public Health Prep. 2021 Apr 19:1-4. doi: 10.1017/dmp.2021.123.
3
Herd Immunity: Understanding COVID-19.群体免疫：了解 COVID-19。
Immunity. 2020 May 19;52(5):737-741. doi: 10.1016/j.immuni.2020.04.012.
4
SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission.SARS-CoV-2 无症状和有症状患者及输血传播风险。
Transfusion. 2020 Jun;60(6):1119-1122. doi: 10.1111/trf.15841. Epub 2020 May 27.
5
Post-donation COVID-19 identification in blood donors.献血者中捐献后新型冠状病毒肺炎的识别
Vox Sang. 2020 Nov;115(8):601-602. doi: 10.1111/vox.12925. Epub 2020 Apr 21.
Zotero 插件